Marksans Pharma Q2 FY27 PAT surges 44.8% to Rs. 143.5 Cr

The operational efficiency of Marksans Pharma saw massive acceleration

Glenmark Pharmaceuticals Q2 PAT plunges 57% to Rs. 264 crore amid North American slump; India sales grow 14%

The company's consolidated total revenue from operations for the July–September quarter fell 29.8% to Rs. 4,247.32 crore

SMS Pharma Q2 PAT jumps 57% to Rs 40 crore as revenue surges 30%

Its Rs 280 crore capital expenditure programme remains on track for completion by FY27, with Rs 160 crore already deployed

Hester Biosciences Q2 net profit jumps 44% to Rs 20.63 crore; revenue surges 38%

Operating performance also strengthened significantly, with consolidated EBITDA climbing 55% year-on-year to Rs 36.52 crore

Ennature Bio Pharma lists on NSE & BSE as it bets big on science-backed nutraceuticals

The biopharma division of IGL reported net revenue of Rs 246 crore, EBITDA of Rs 29 crore and a gross margin of 40.1% in FY26

Emcure Pharmaceuticals posts 24% revenue growth in Q2 FY27; profit jumps 29%

International operations emerged as the biggest growth driver, posting a 34.5% increase in revenue to Rs 16,652 million

Fresenius strikes landmark WuXi Biologics deal to nearly triple biosimilar pipeline to 66 molecules

Under the deal, Fresenius will retain exclusive global commercialization rights, including marketing authorizations

Beauty & beyond: BASF unveils breakthrough ingredient for post-laser skin recovery

Clinical results suggest significant potential

Dabur reports 11. 7% growth in Q2 PAT at Rs. 505 Cr

India FMCG business grows 10.7%; International business grows 20%

Alembic Pharma expands US complex generics portfolio via DifGen partnership

The expanded collaboration combines DifGen’s development and US manufacturing capabilities with Alembic’s established US commercial platform

Alembic Pharmaceuticals Q2 PAT jumps 81% to Rs. 335 crore on 36% revenue growth

Novo Nordisk raises 2026 outlook after stronger-than-expected Q3 driven by obesity drug sales

Wegovy pill generates DKK 5.4 billion in quarterly sales as GLP-1 demand fuels growth

Aurobindo Pharma posts record quarterly revenue of Rs 10,263 crore as net profit jumps 32.5%

Strong growth across US, Europe and emerging markets drives 24% revenue surge

Lupin Q2 profit plunges 22.2% despite 14% revenue growth

The company reported sales of Rs 7,785.5 crore for Q2 FY27

Zydus Lifesciences Q2 revenue jumps 29% to Rs 7,910 crore but net profit falls 27%

Biocon Q2 profit at Rs 41 crore as revenue rises 2%, biopharma biz grows 5%

Merck to sell CDMO biz to Lonza in mid-triple-digit million-Euro deal

The move will give Merck a more concentrated Life Science portfolio

Bayer raises 2026 outlook as pharma growth accelerates

While Pharmaceuticals gathered momentum, Crop Science and Consumer Health continued to perform in line with their respective targets despite challenging market conditions

Pfizer posts strong Q3 results raising 2026 forecast as new products drive growth

A major growth driver was Pfizer's launched and acquired product portfolio, which recorded a striking 32% year-over-year operational revenue increase.

Cambrex pumps $120 million into Iowa facility to boosts drug manufacturing capacity by 25%

The project will add 160,000 litres of manufacturing capacity, increasing the facility's total capacity by approximately 25% to nearly one million litres